RecruitingNCT07026240

Post-operative Monitoring of Gastric Cancer

Post-operative Monitoring of Gastric Cancer Using Circulating DNA in Blood Samples

Sponsor

Suzhou Huhu Health & Technology Inc.

Enrollment

258 participants

Start Date

Feb 18, 2024

Study Type

OBSERVATIONAL

Conditions

This study is to determine the performance of non-invasive new multi-target biomarkers in the post-operative monitoring of gastric cancer.

Min Age: 18 Years

Subject age over 18.
Subject has stomach discomfort, and seek medical attention at the Gastric Surgery Department of our center.
Subject has or will have gastroscopy and/or pathological examination results at this center.
Subject must be able to fully understand the informed consent form and be able to personally sign it.

Subject has serious heart, liver, kidney dysfunction, or mental illness.
Subject diagnosed previously with any kind of malignant tumor.
Subject is known to be infected with HIV or other related diseases (considering interference from the use of immune drugs).
Subject is receiving targeted drugs, immunosuppressants, immunomodulators, and biological therapies.
Researchers believe that subject is not suitable for enrollment.
Subject can not supply sufficient sample to complete this experiment.

DIAGNOSTIC_TESTDNA test

a new non-invasive detection method for postoperative monitoring of gastric cancer in the blood

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT07026240